Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if she will provide the resources necessary to the MHRA to achieve the UK’s HealthTech regulatory ambition.

The Government is committed to providing the Medicines and Healthcare products Regulatory Agency (MHRA) with the resources to foster the United Kingdom’s regulatory ambitions on innovative medicines and medical devices. Funding for the MHRA is determined in advance through collaborative Spending Review processes. Funding from the Spending Review has been provided for its transformation programme to facilitate the MHRA’s aim of becoming a global exemplar in public health and patient safety. The MHRA is currently consulting on increases to its statutory fees to ensure all costs involved in delivery are recovered.